Cover Image
市場調查報告書

BiOrion Technologies B.V.- 產品平台檢討

BiOrion Technologies B.V. - Product Pipeline Review - 2015

出版商 Global Markets Direct 商品編碼 311913
出版日期 內容資訊 英文 19 Pages
訂單完成後即時交付
價格
Back to Top
BiOrion Technologies B.V.- 產品平台檢討 BiOrion Technologies B.V. - Product Pipeline Review - 2015
出版日期: 2015年04月15日 內容資訊: 英文 19 Pages
簡介

BiOrion Technologies B.V.是總公司設置於荷蘭的生物製藥企業,正在開發纖維症及癌症相關的纖維母細胞治療藥。為了將藥劑送達纖維組織,或是癌細胞,而利用胜肽、長鎖鏈蛋白質、微脂體、細胞激素等相關的技術。

本報告提供BiOrion Technologies B.V.的治療藥開發平台現狀及各開發階段比較分析,提供您藥物標的,作用機制,給藥途徑,各分子類型的治療藥評估,最新的企業新聞和發表,後期階段及中止的計劃等相關資訊。

目錄

BiOrion Technologies B.V.的基本資料

  • BiOrion Technologies B.V.概要
  • 主要資訊
  • 企業資料

BiOrion Technologies B.V.:R&D概要

  • 主要的治療範圍

BiOrion Technologies B.V.:開發平台評估

  • 各開發階段的開發中產品
  • 單劑產品

BiOrion Technologies B.V.:開發中產品概況

  • 初期階段的開發中產品
    • 前臨床階段的產品/聯合治療模式

BiOrion Technologies B.V.:藥物簡介

  • BOT-161
  • BOT-162
  • BOT-191

BiOrion Technologies B.V.:開發平台分析

  • 標的別
  • 各分子類型
  • 各作用機制

BiOrion Technologies B.V.:開發暫停中的計劃

BiOrion Technologies B.V.:總公司和子公司的所在地

  • 總公司

附錄

圖表一覽

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GMDHC06945CDB

Summary

Global Markets Direct's, 'BiOrion Technologies B.V. - Product Pipeline Review - 2015', provides an overview of the BiOrion Technologies B.V.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of BiOrion Technologies B.V.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of BiOrion Technologies B.V. including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of BiOrion Technologies B.V.'s human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the BiOrion Technologies B.V.'s pipeline products

Reasons to buy

  • Evaluate BiOrion Technologies B.V.'s strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of BiOrion Technologies B.V. in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the BiOrion Technologies B.V.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of BiOrion Technologies B.V. and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of BiOrion Technologies B.V.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of BiOrion Technologies B.V. and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • BiOrion Technologies B.V. Snapshot
    • BiOrion Technologies B.V. Overview
    • Key Information
    • Key Facts
  • BiOrion Technologies B.V. - Research and Development Overview
    • Key Therapeutic Areas
  • BiOrion Technologies B.V. - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
  • BiOrion Technologies B.V. - Pipeline Products Glance
    • BiOrion Technologies B.V. - Early Stage Pipeline Products
      • Preclinical Products/Combination Treatment Modalities
  • BiOrion Technologies B.V. - Drug Profiles
    • BOT-161
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • BOT-162
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • BOT-191
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • BiOrion Technologies B.V. - Pipeline Analysis
  • BiOrion Technologies B.V. - Pipeline Products by Target
  • BiOrion Technologies B.V. - Pipeline Products by Molecule Type
  • BiOrion Technologies B.V. - Pipeline Products by Mechanism of Action
  • BiOrion Technologies B.V. - Dormant Projects
  • BiOrion Technologies B.V. - Locations And Subsidiaries
    • Head Office
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • BiOrion Technologies B.V., Key Information
  • BiOrion Technologies B.V., Key Facts
  • BiOrion Technologies B.V. - Pipeline by Indication, 2015
  • BiOrion Technologies B.V. - Pipeline by Stage of Development, 2015
  • BiOrion Technologies B.V. - Monotherapy Products in Pipeline, 2015
  • BiOrion Technologies B.V. - Preclinical, 2015
  • BiOrion Technologies B.V. - Pipeline by Target, 2015
  • BiOrion Technologies B.V. - Pipeline by Molecule Type, 2015
  • BiOrion Technologies B.V. - Pipeline Products by Mechanism of Action, 2015
  • BiOrion Technologies B.V. - Dormant Developmental Projects,2015

List of Figures

  • BiOrion Technologies B.V. - Pipeline by Top 10 Indication, 2015
  • BiOrion Technologies B.V. - Pipeline by Top 10 Molecule Type, 2015
Back to Top